Porojnicu Alina, Robsahm Trude Eid, Berg Jens Petter, Moan Johan
Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):675-8. doi: 10.1016/j.jsbmb.2006.12.031. Epub 2007 Jan 16.
The calcidiol level in a group of Norwegians (14,000 individuals, age range 16-80) was found to be highest in late summer. The seasonal variation was larger for young than for old persons. The calcitriol concentration was practically constant throughout the year. Younger persons had less calcidiol and more calcitriol than older persons, indicating that the conversion of calcidiol to calcitriol is more efficient in younger persons. A seasonal variation of prognosis of cancer (colon-, breast-, prostate- cancer and Hodgkin lymphoma) was found. The survival is highest for summer and autumn diagnosis, corresponding to maximal calcidiol levels. Thus, calcidiol may act synergistically with traditional treatment modalities. In view of these calcitriol and calcidiol data, the seasonal variation of cancer survival may be related to the calcidiol gradient, indicating that this Vitamin D metabolite may be more important than believed so far.
在一组挪威人(14000人,年龄范围16 - 80岁)中,发现骨化二醇水平在夏末最高。年轻人的季节变化比老年人更大。骨化三醇浓度全年基本恒定。年轻人的骨化二醇比老年人少,骨化三醇比老年人多,这表明年轻人中骨化二醇向骨化三醇的转化更有效。研究发现癌症(结肠癌、乳腺癌、前列腺癌和霍奇金淋巴瘤)的预后存在季节性变化。夏季和秋季诊断的患者生存率最高,这与骨化二醇水平最高相对应。因此,骨化二醇可能与传统治疗方式协同作用。鉴于这些骨化三醇和骨化二醇的数据,癌症生存率的季节性变化可能与骨化二醇梯度有关,这表明这种维生素D代谢物可能比目前认为的更重要。